Regenerative medicine in rheumatic disease-progress in tissue engineering

Nature Reviews Rheumatology

Volumn 8, Issue 8, 2012, Pages 493-498

  Ringe, Jochen ^a   Burmester, Gerd R ^a   Sittinger, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; HYALURONIC ACID; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA1;

AUTOTRANSPLANTATION; BONE MARROW CELL; CARTILAGE INJURY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CELL THERAPY; CELL TRANSPORT; CHONDROCYTE IMPLANTATION; CHONDROGENESIS; HUMAN; IMMUNOMODULATION; INFLAMMATION; MESENCHYMAL STEM CELL; MICROFRACTURE; NONHUMAN; OSTEOARTHRITIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; RHEUMATIC DISEASE; THERAPY EFFECT; TISSUE ENGINEERING;

ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CHONDROCYTES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; OSTEOARTHRITIS; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 84864632376     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2012.98     Document Type: Review

References (53)

1. Grande, D. A., Pitman, M. I., Peterson, L., Menche, D. and Klein, M. The repair of experimentally produced defects in rabbit articular cartilage by autologous chondrocyte transplantation. J. Orthop. Res. 7, 208-218 (1989
2. Daher, R. J., Chahine, N. O., Greenberg, A. S., Sgaglione, N. A. and Grande, D. A. New methods to diagnose and treat cartilage degeneration. Nat. Rev. Rheumatol. 5, 599-607 (2009
3. Ossendorf, C. et al. Treatment of posttraumatic and focal osteoarthritic cartilage defects of the knee with autologous polymer-based three-dimensional chondrocyte grafts: 2 year clinical results. Arthritis Res. Ther. 9, R41 (2007
4. Kon, E. et al. Second-generation autologous chondrocyte transplantation: MRI findings and clinical correlations at a minimum 5 year follow-up. Eur. J. Radiol. 79, 382-388 (2011
5. Behrens, P., Bitter, T., Kurz, B. and Russlies, M. Matrix-associated autologous chondrocyte transplantation/implantation (MACT/MACI)-5-year follow-up. Knee 13, 194-202 (2006
6. Sittinger, M. and Burmester, G. R. Can engineered cartilage transplants be used for treating rheumatic diseases? Nat. Clin. Pract. Rheumatol. 2, 172-173 (2006
7. Peterson, L., Vasiliadis, H. S., Brittberg, M. and Lindahl, A. Autologous chondrocyte implantation: A long-term follow-up. Am. J. Sports Med. 38, 1117-1124 (2010
8. Knutsen, G. et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J. Bone Joint Surg. Am. 89, 2105-2112 (2007
9. Saris, D. B. et al. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am. J. Sports Med. 36, 235-246 (2008
10. Kreuz, P. C. et al. Repair of focal cartilage defects with scaffold-assisted autologous chondrocyte grafts: Clinical and biomechanical results 48 months after transplantation. Am. J. Sports Med. 39, 1697-1705 (2011
11. Benthien, J. P., Schwaninger, M. and Behrens, P. We do not have evidence based methods for the treatment of cartilage defects in the knee. Knee Surg. Sports Traumatol. Arthrosc. 19, 543-552 (2011
12. Bartlett, W. et al. Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: A prospective, randomised study. J. Bone Joint Surg. Br. 87, 640-645 (2005
13. Dehne, T., Karlsson, C., Ringe, J., Sittinger, M. and Lindahl, A. Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation. Arthritis Res. Ther. 11, R133 (2009
14. Hollander, A. P. et al. Maturation of tissue engineered cartilage implanted in injured and osteoarthritic human knees. Tissue Eng. 12, 1787-1798 (2006
15. Kreuz, P. C., Muller, S., Ossendorf, C., Kaps, C. and Erggelet, C. Treatment of focal degenerative cartilage defects with polymer-based autologous chondrocyte grafts: Four-year clinical results. Arthritis Res. Ther. 11, R33 (2009
16. Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147 (1999
17. Jorgensen, C. and Noel, D. Mesenchymal stem cells in osteoarticular diseases. Regen. Med. 6, 44-51 (2011
18. Murphy, J. M., Fink, D. J., Hunziker, E. B. and Barry, F. P. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum. 48, 3464-3474 (2003
19. Davatchi, F., Abdollahi, B. S., Mohyeddin, M., Shahram, F. and Nikbin, B. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int. J. Rheum. Dis. 14, 211-215 (2011
20. Nejadnik, H., Hui, J. H., Feng Choong, E. P., Tai, B. C. and Lee, E. H. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: An observational cohort study. Am. J. Sports Med. 38, 1110-1116 (2010
21. Kuroda, R. et al. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage 15, 226-231 (2007
22. Wakitani, S. et al. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: Two case reports. Cell. Transplant. 13, 595-600 (2004
23. Wakitani, S. et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 10, 199-206 (2002
24. Kafienah, W. et al. Three-dimensional cartilage tissue engineering using adult stem cells from osteoarthritis patients. Arthritis Rheum. 56, 177-187 (2007
25. Ringe, J. and Sittinger, M. Tissue engineering in the rheumatic diseases. Arthritis Res. Ther. 11, 211 (2009
26. Mohal, J. S., Tailor, H. D. and Khan, W. S. Sources of adult mesenchymal stem cells and their applicability for musculoskeletal applications. Curr. Stem Cell Res. Ther. 7, 103-109 (2012
27. Pei, M., He, F. and Vunjak-Novakovic, G. Synovium-derived stem cell-based chondrogenesis. Differentiation 76, 1044-1056 (2008
28. De Bari, C., Dell'Accio, F. and Luyten, F. P. Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum. 50, 142-150 (2004
29. Kim, M. J. et al. Generation of human induced pluripotent stem cells from osteoarthritis patient-derived synovial cells. Arthritis Rheum. 63, 3010-3021 (2011
30. Toh, W. S., Lee, E. H. and Cao, T. Potential of human embryonic stem cells in cartilage tissue engineering and regenerative medicine. Stem Cell Rev. 7, 544-559 (2011
31. Benthien, J. P. and Behrens, P. The treatment of chondral and osteochondral defects of the knee with autologous matrix-induced chondrogenesis (AMIC): Method description and recent developments. Knee Surg. Sports Traumatol. Arthrosc. 19, 1316-1319 (2011
32. Kusano, T. et al. Treatment of isolated chondral and osteochondral defects in the knee by autologous matrix-induced chondrogenesis (AMIC). Knee Surg. Sports Traumatol. Arthrosc. http://dx.doi.org/10.1007/s00167 011 1840-1842.
33. Erggelet, C. et al. Formation of cartilage repair tissue in articular cartilage defects pretreated with microfracture and covered with cell-free polymer-based implants. J. Orthop. Res. 27, 1353-1360 (2009
34. Patrascu, J. M., Freymann, U., Kaps, C. and Poenaru, D. V. Repair of a post-traumatic cartilage defect with a cell-free polymer-based cartilage implant: A follow-up at two years by MRI and histological review. J. Bone Joint Surg. Br. 92, 1160-1163 (2010
35. Siclari, A., Mascaro, G., Gentili, C., Cancedda, R. and Boux, E. A cell-free scaffold-based cartilage repair provides improved function hyaline-like repair at one year. Clin. Orthop. Relat. Res. 470, 910-919 (2012
36. Pretzel, D. et al. Relative percentage and zonal distribution of mesenchymal progenitor cells in human osteoarthritic and normal cartilage. Arthritis Res. Ther. 13, R64 (2011
37. Stich, S. et al. Gene expression profiling of human mesenchymal stem cells chemotactically induced with CXCL12. Cell Tissue Res. 336, 225-236 (2009
38. Kruger, J. P. et al. Human platelet-rich plasma stimulates migration and chondrogenic differentiation of human subchondral progenitor cells. J. Orthop. Res. 30, 845-852 (2011
39. Fiedler, J., Roderer, G., Gunther, K. P. and Brenner, R. E. BMP 2, BMP 4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J. Cell. Biochem. 87, 305-312 (2002
40. Endres, M. et al. Synovial fluid recruits human mesenchymal progenitors from subchondral spongious bone marrow. J. Orthop. Res. 25, 1299-1307 (2007
41. Kalwitz, G. et al. Chemokine profile of human serum from whole blood: Migratory effects of CXCL 10 and CXCL 11 on human mesenchymal stem cells. Connect. Tissue Res. 51, 113-122 (2010
42. Fortier, L. A., Barker, J. U., Strauss, E. J., McCarrel, T. M. and Cole, B. J. The role of growth factors in cartilage repair. Clin. Orthop. Relat. Res.469, 2706-2715 (2011
43. US National Library of Medicine. Study of TG-C in patients with grade 3 degenerative joint diseases of the knee. ClinialTrial.gov [online], http://clinicaltrials.gov/ct2/show/NCT01221441?term=NCT01221441&rank=1 (2012
44. Chen, W., Tabata, Y. and Tong, Y. W. Fabricating tissue engineering scaffolds for simultaneous cell growth and drug delivery. Curr. Pharm. Des. 16, 2388-2394 (2010
45. Andreas, K. et al. Biodegradable insulin-loaded PLGA microspheres fabricated by three different emulsification techniques: Investigation for cartilage tissue engineering. Acta Biomater. 7, 1485-1495 (2011
46. Park, J. S., Yang, H. N., Woo, D. G., Chung, H. M. and Park, K. H. In vitro and in vivo chondrogenesis of rabbit bone marrow-derived stromal cells in fibrin matrix mixed with growth factor loaded in nanoparticles. Tissue Eng. Part A 15, 2163-2175 (2009
47. Da Silva, M. A., Martins, A., Teixeira, A. A., Reis, R. L. and Neves, N. M. Impact of biological agents and tissue engineering approaches on the treatment of rheumatic diseases. Tissue Eng. Part B Rev. 16, 331-339 (2010
48. Ghannam, S., Bouffi, C., Djouad, F., Jorgensen, C. and Noel, D. Immunosuppression by mesenchymal stem cells: Mechanisms and clinical applications. Stem Cell Res. Ther. 1, 2 (2010
49. European Medicines Agency, CAT Secretariat and US Food and Drug Administration. Regen. Med. 6, 90-96 (2011
50. Halme, D. G. and Kessler, D. A. FDA regulation of stem cell based therapies. N. Engl. J. Med. 355, 1730-1735 (2006
51. McAllister, T. N., Dusserre, N., Maruszewski, M. and L'Heureux, N. Cell-based therapeutics from an economic perspective: Primed for a commercial success or a research sinkhole? Regen. Med. 3, 925-937 (2008
52. Gerlier, L. et al. The cost utility of autologous chondrocytes implantation using ChondroCelect(R) in symptomatic knee cartilage lesions in Belgium. Pharmacoeconomics 28, 1129-1146 (2010
53. Rayment, E. A. and Williams, D. J. Concise review: Mind the gap: Challenges in characterizing and quantifying cell- and tissue-based therapies for clinical translation. Stem Cells 28, 996-1004 (2010)